Nanthealth Stock Today

NH -  USA Stock  

USD 0.48  0.06  11.11%

Market Performance
0 of 100
Odds Of Distress
Over 84
Nanthealth is trading at 0.48 as of the 25th of June 2022. This is a -11.11 percent down since the beginning of the trading day. The stock's open price was 0.54. Nanthealth has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for Nanthealth are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 26th of May 2022 and ending today, the 25th of June 2022. Click here to learn more.
Fiscal Year End
Business Domain
Health Care Equipment & Services
IPO Date
2nd of June 2016
Health Care
NantHealth, Inc., together with its subsidiaries, operates as a healthcare IT company in the United States, Canada, and the United Kingdom. The company was incorporated in 2010 and is headquartered in Morrisville, North Carolina. Nanthealth operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. The company has 115.44 M outstanding shares of which 973.85 K shares are now sold short in the market by investors with about 10.81 days to cover all shorted shares. More on Nanthealth

Moving against Nanthealth

0.82VTNRVertex Energy Normal TradingPairCorr
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores

Nanthealth Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. If you consider yourself one of those investors, make sure you clearly understand your entering position. Nanthealth's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Nanthealth or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Nanthealth generated a negative expected return over the last 90 days
Nanthealth has high historical volatility and very poor performance
Nanthealth has some characteristics of a very speculative penny stock
Nanthealth has a very high chance of going through financial distress in the upcoming years
The company generated the yearly revenue of 62.65 M. Annual Net Loss to common stockholders was (58.28 M) with gross profit of 39.83 M.
Nanthealth reports about 29.08 M in cash with (27.69 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.25.
Nanthealth has a frail financial position based on the latest SEC disclosures
Roughly 58.0% of the company outstanding shares are owned by corporate insiders
Latest headline from Precision Medicine Software Market Investment Analysis Designer Women - Designer Women
New SymbolCNH
Average Analyst Recommendation
Analysts covering Nanthealth report their recommendations after researching Nanthealth's financial statements, talking to executives and customers, or listening in on Nanthealth's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Nanthealth. The Nanthealth consensus assessment is calculated by taking the average forecast from all of the analysts covering Nanthealth.
Strong Buy2 Opinions
Piotroski F Score
Piotroski F-Score is a popular financial indicator that puts together nine criteria to evaluate the financial strength of Nanthealth based on its profitability, leverage, liquidity, source of funds, and operating efficiency. It is an academic score (developed by Joseph Piotroski in 2002) to determine the current strength of Nanthealth financial position. Scores of 8 and 9 are usually classified as strong value stocks, whereas scores of 2 or below are considered weak value stocks.
 3 - FrailDetails
Current ValueLast YearChange From Last Year 10 Year Trend
Weighted Average Shares131.2 M125.5 M
Sufficiently Up
Slightly volatile
Weighted Average Shares Diluted131.2 M125.5 M
Sufficiently Up
Slightly volatile
Total Assets421.4 M329.3 M
Significantly Up
Very volatile
Total Liabilities215.9 M255.2 M
Fairly Down
Slightly volatile
Current Assets46.6 M45.4 M
Fairly Up
Slightly volatile
Current Liabilities52.2 M42 M
Fairly Up
Slightly volatile
Total Debt236 M254.3 M
Significantly Down
Slightly volatile
Gross Margin40.7245.47
Moderately Down
Slightly volatile
Asset Turnover0.190.22
Fairly Down
Slightly volatile
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Nanthealth's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Strong SellUndervalued
Financial Strength
Nanthealth's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Nanthealth's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Nanthealth's financial leverage. It provides some insight into what part of Nanthealth's total assets is financed by creditors.
Share Download
Share Download
By using current balance sheet information, investors can analyze the liability, assets, and equity on Nanthealth's books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how Nanthealth deploys its capital and how much of that capital is borrowed.
Nanthealth cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company reports 258.48 M of total liabilities with total debt to equity ratio (D/E) of 44.9, which implies that the company may not be able to produce enough cash to satisfy its debt commitments. Nanthealth has a current ratio of 1.38, which is generally considered normal. Debt can assist Nanthealth until it has trouble settling it off, either with new capital or with free cash flow. So, Nanthealth's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Nanthealth sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Nanthealth to invest in growth at high rates of return. When we think about Nanthealth's use of debt, we should always consider it together with cash and equity.

Operating Cash Flow

(28.77 Million)Share
Nanthealth (NH) is traded on NASDAQ Exchange in USA and employs 326 people. The company currently falls under 'Micro-Cap' category with market capitalization of 58.9 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Nanthealth's market, we take the total number of its shares issued and multiply it by Nanthealth's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Nanthealth is active under Healthcare sector as part of Health Information Services industry. The entity has 115.44 M outstanding shares of which 973.85 K shares are now sold short in the market by investors with about 10.81 days to cover all shorted shares. Nanthealth reports about 29.08 M in cash with (27.69 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.25.
Check Nanthealth Probability Of Bankruptcy
Nanthealth maintains a total of one hundred fifteen million four hundred fourty thousand outstanding shares. Nanthealth holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how much assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Ownership Allocation (%)

Check Nanthealth Ownership Details

Nanthealth Stock Price Odds Analysis

What are Nanthealth's target price odds to finish over the current price? In reference to a normal probability distribution, the odds of Nanthealth jumping above the current price in 90 days from now is roughly 96.0%. The Nanthealth probability density function shows the probability of Nanthealth stock to fall within a particular range of prices over 90 days. Allowing for the 90-day total investment horizon Nanthealth has a beta of 0.5682. This indicates as returns on the market go up, Nanthealth average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Nanthealth will be expected to be much smaller as well. Additionally, the company has a negative alpha, implying that the risk taken by holding this instrument is not justified. Nanthealth is significantly underperforming DOW.
  Odds Below 0.48HorizonTargetOdds Above 0.48
3.96%90 days
Based on a normal probability distribution, the odds of Nanthealth to move above the current price in 90 days from now is roughly 96.0 (This Nanthealth probability density function shows the probability of Nanthealth Stock to fall within a particular range of prices over 90 days) .

Nanthealth Historical Income Statement

Nanthealth Income Statement is one of the three primary financial statements used for reporting Nanthealth's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Nanthealth revenue and expense. Nanthealth Income Statement primarily focuses on the company's revenues and expenses during a particular period.
Nanthealth Research and Development Expense is most likely to increase significantly in the upcoming years. The last year's value of Research and Development Expense was reported at 15.55 Million. The current Selling General and Administrative Expense is estimated to increase to about 50.5 M, while Direct Expenses is projected to decrease to roughly 39.3 M. View More Fundamentals

Nanthealth Stock Against Markets

Picking the right benchmark for Nanthealth stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Nanthealth stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Nanthealth is critical whether you are bullish or bearish towards Nanthealth at a given time.

Similar Equity Warning - NH

Nanthealth was forked

The entity Nanthealth with a symbol NH was recently forked. You can potentially use CH ENERGY GROUP with a symbol CNH from now on.

Nanthealth Corporate Directors

Nanthealth corporate directors refer to members of a Nanthealth board of directors. The board of directors generally takes responsibility for the Nanthealth's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Nanthealth's board members must vote for the resolution. The Nanthealth board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Michael Blaszyk - Independent DirectorProfile
Kirk Calhoun - Independent DirectorProfile
Mark Burnett - Independent DirectorProfile
Michael Sitrick - Independent DirectorProfile

Investing Nanthealth

You need to understand the risk of investing before taking a position in Nanthealth. The danger of trading Nanthealth is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Nanthealth is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Nanthealth. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Nanthealth is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Additionally, see Stocks Correlation. Note that the Nanthealth information on this page should be used as a complementary analysis to other Nanthealth's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Complementary Tools for Nanthealth Stock analysis

When running Nanthealth price analysis, check to measure Nanthealth's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nanthealth is operating at the current time. Most of Nanthealth's value examination focuses on studying past and present price action to predict the probability of Nanthealth's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Nanthealth's price. Additionally, you may evaluate how the addition of Nanthealth to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Is Nanthealth's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nanthealth. If investors know Nanthealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nanthealth listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
64.7 M
Quarterly Revenue Growth YOY
Return On Assets
The market value of Nanthealth is measured differently than its book value, which is the value of Nanthealth that is recorded on the company's balance sheet. Investors also form their own opinion of Nanthealth's value that differs from its market value or its book value, called intrinsic value, which is Nanthealth's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nanthealth's market value can be influenced by many factors that don't directly affect Nanthealth's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nanthealth's value and its price as these two are different measures arrived at by different means. Investors typically determine Nanthealth value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nanthealth's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.